bladder cancer
Coverage of bladder cancer in the Nexus archive.
- Egypt Cancer Mortality Falls 23.5% as State Health Campaigns Pay Off
Egypt's age-standardised cancer mortality fell 23.5% between 2022 and 2024, with annual deaths dropping from 95,300 to 80,500. New cancer cases decreased 17.2% despite a 9.8% population increase, driven by declines in liver and bladder cancers. State health campaigns are credited for these improvements.
- 5 ON YOUR SIDE: Heavy metals in rice
Consumer Reports found inorganic arsenic, a known carcinogen, in all 52 tested rice products. Brown rice and certain types like basmati and sushi rice vary in arsenic levels, with over 40% of products posing potential cancer and diabetes risks. Consumer Reports recommends reducing rice consumption, using alternative grains, and specific cooking methods to lower exposure.
- Tracey Emin proudly poses in her underwear as she celebrates her 63rd birthday and says 'I want to live as long as possible and work until the day I die' following bladder cancer battle
Tracey Emin celebrates her 63rd birthday by posing in her underwear and expresses her desire to live and work until her death after battling bladder cancer.
- Aspirin and Bladder Cancer; Oncology Workforce Shortage; 'Exploding Immune Cells'
A large Danish study suggests aspirin use may indirectly help uncover asymptomatic bladder cancer. The article also mentions an oncology workforce shortage and a trial with concerning mortality and lack of survival benefit.
- Cancer breakthrough bonanza: Does string of advances signal turning point?
A new pill doubling survival time for pancreatic cancer and major advancements in breast, bladder, and neck cancer treatments were announced at the American Society of Clinical Oncology conference in Chicago, sparking widespread medical community acclaim.
- Doctors hail drug that spares bladder cancer patients ‘life-changing’ surgery
Doctors are praising the drug Durvalumab for its ability to prevent bladder cancer tumors from returning and avoid life-changing surgery. A trial led by the London-based Institute of Cancer Research showed promising results for the treatment.